Sign in

CIK 0000906709

  • Non-accelerated filer
  • Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943134940
Phone
+1 415-482-5300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-05-16 NORTHCOTT JOHN SVP & Chief Commercial Officer Sale −4,592 $3.95 $18K 223,210
2022-02-16 NORTHCOTT JOHN SVP & Chief Commercial Officer Sale −4,852 $10.95 $53K 227,802
2021-12-16 NORTHCOTT JOHN SVP & Chief Commercial Officer Grant or award +37,800 232,654
2021-12-16 NORTHCOTT JOHN SVP & Chief Commercial Officer Grant or award · Stock Option +67,150 67,150
2021-11-16 NORTHCOTT JOHN SVP & Chief Commercial Officer Sale −6,061 $13.16 $80K 194,854
2021-08-16 NORTHCOTT JOHN SVP & Chief Commercial Officer Sale −6,192 $13.83 $86K 200,915
2021-05-17 NORTHCOTT JOHN SVP & Chief Commercial Officer Sale −6,085 $18.30 $111K 207,107
2021-02-16 NORTHCOTT JOHN SVP & Chief Commercial Officer Sale −15,358 $22.37 $344K 213,192
2020-12-18 NORTHCOTT JOHN SVP & Chief Commercial Officer Grant or award +28,550 228,550
2020-12-18 NORTHCOTT JOHN SVP & Chief Commercial Officer Grant or award · Stock Option +51,000 51,000
2019-12-02 NORTHCOTT JOHN SVP & Chief Commercial Officer Grant or award +200,000 200,000
2019-12-02 NORTHCOTT JOHN SVP & Chief Commercial Officer Grant or award · Stock Option +200,000 200,000

Page 1 of 1 · 12 trades